Hello SLTs/SLPs and all interested! We are running a free webinar on Apple free voice banking with a focus on what you should know for your clients, who it is better for and what issues may be. Ask any questions, discuss. All welcome & free fegister here mnd.eventsair.com/aac-traini…
In this webinar Dr Alan Stanley will outline the principles behind providing the best possible care for people with MND (pwMND), and future treatment avenues. Targeted at MDT members caring for pwMND, but everyone welcome to attend. Register & more info@ bit.ly/3Ple9Yu
Pain in #ALS is often not recognized enough. A few years ago, we @kingsmnd@AmmarAlChalabi created leaflets about #pain for people with ALS & for health care professionals used in specialist clinics & @mndassoc. Both leaflets received the endorsement of the Royal College of GP
This new technique could provide valuable insights into the MND disease process that we can't obtain currently;
Mature ‘lab grown’ neurons hold promise for ALS and other neurodegenerative diseases
lesturnerals.org/mature-lab-…
🚨 New blog! 🚨
Today's blog delves deeper into whether signs of #MND#ALS can be detected before symptoms appear. Observing changes within the body before symptoms occur could help lead to earlier diagnoses and treatment of the disease.
Read more ⬇
mndresearch.blog/2023/01/06/…
It's so great to see more researchers utilising King’s #ALS Clinical Staging system in clinical trials. Get in touch if you want to use the system in your research. Also we developed an online staging course part of @TRICALS_cureALS here is the link elearning.elevatehealth.eu/l…
✨ It’s the final day of the 33rd International Symposium on #ALS#MND! ✨
We hope you have had a productive Symposium so far and enjoy the final day. Don’t forget if you missed a session you can watch on-demand until 8 March 2022!
#alsmndsymp🌐
ALT A man and woman in the tv studio set of the 33rd International Symposium on ALS/MND
The #clinicaltrial session happened at #alsmndsymp yesterday. 💊
We know the #MND#ALS community are eager to hear updates from trials, so we have put together an overview of the 4 trials discussed at the session yesterday on our blog.
Read here ⬇
mndresearch.blog/2022/12/07/…
Open-label extension data of Tofersen #alsmndsymp Most data already available in NEJM paper. Surprising large differences between clinical endpoints (e.g. ALSAQ-5 & EQ5D vs ALSFRS-R), confirming the limitations of using scales like the ALSFRS-R in multidimensional disease?
Registered for #alsmndsymp? Going to be on the go next week? Make sure you download the FREE Symposium app! 📱 You can watch live sessions, browse the agenda and more all on your iPhone/Android!
App Store 👉itunes.apple.com/us/app/the-…
Google Play 👉
play.google.com/store/apps/d…
ALT Download the mobile app for the 33rd International Symposium on ALS/MND. Includes QR codes for the App store and google play
Come and work with our team at Sheffield aiming to end MND. An exciting tenured Grade 9 senior research fellow linked with NIHR. jobs.shef.ac.uk/sap/bc/webdy…
Register now to attend this free satellite meeting on 6 Dec. Highlights include recent developments in ALS clinical trials, with specific focus in relation to precision therapy, new trial, diagnostic and functional approaches, as well as trial updates.
Our PhD student @kyrah_thumbadoo was the overall winner today and took home the Hilary Halloway prize at the BIRU annual imaging competition @FMHS_UoA. Job well done!! Proud supervisors: @EmmaLScotter @MDragunow @VDieriks
We have some 230 people coming to the Alliance Meeting and 440 to the Allied Professionals Forum including the largest contingent of people living with ALS/MND attending in history. You can still join us at pheedloop.com/EVEOHKCATAZOQ/…#ALSMNDWithoutBorders#ALS#MND